LGC offers new bridging assay for improved COVID-19 antibody detection
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
From Monday, July 20: Join world-leading clinical scientists and healthcare professionals online - free to attend
The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab
Dr. Emma Walker reveals how transitioning from immunoassays to LC-MS/MS has helped deliver better diagnostic services in her lab
Partnership to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors
Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers
Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility
This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19
Gallant ICD and CRT-D devices feature a patient-preferred design without compromising on battery longevity and compatibility with magnetic resonance imaging (MRI)
Scientists are harnessing machine learning to make accurate measurements of breast cancer risk from a patient’s blood cells
Prof. Ishii explains how high-sensitivity troponin I assays and a 1-hour algorithm can be best used for early diagnosis and treatment of myocardial infarction
This unique feature is offered as a package that allows the user to measure polarization spectra in either transmission or reflectance modes